24 results on '"Mocci, Ignazia"'
Search Results
2. Neuroprotective Effects of the Nutraceutical Dehydrozingerone and its C2- symmetric Dimer in a Drosophila Model of Parkinson’s Disease
3. Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C 2 -Symmetric Dimer in a Drosophila Model of Parkinson's Disease.
4. Effects of memantine on mania‐like phenotypes exhibited by Drosophila Shaker mutants
5. Is Increased Neurotoxicity a Burden of the Ageing Brain?
6. Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
7. Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson’s Disease
8. Improvements of Motor Performances in the Drosophila LRRK2 Loss-of-Function Model of Parkinson’s Disease: Effects of Dialyzed Leucocyte Extracts from Human Serum
9. Selective γ-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of γ-hydroxybutyric acid
10. Stereoselectivity of NCS-382 binding to γ-hydroxybutyrate receptor in the rat brain
11. Central effects of 1,4-butanediol are mediated by GABA B receptors via its conversion into γ-hydroxybutyric acid
12. (−) S amisulpride binds with high affinity to cloned dopamine D 3 and D 2 receptors
13. Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson's Disease.
14. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor
15. Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into γ-hydroxybutyric acid
16. (−)S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors
17. Quantitative autoradiographic distribution of γ-hydroxybutyric acid binding sites in human and monkey brain
18. Lanthanides stimulate [3H]tyramine binding in the rat striatum
19. Selected pyrethroid insecticides stimulate glutamate uptake in brain synaptic vesicles
20. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
21. Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into γ-hydroxybutyric acid
22. Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2 WD40 Genetic Model of Parkinson's Disease.
23. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα i/o protein inhibitor.
24. Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.